On the one hand, immune evasion is mediated via genetic inactivation of antigen presentation molecules (Beta2-microglobulin, MHC class I and II) by the tumor, with subsequent loss of expression of these proteins, escaping recognition by cytotoxic CD8+ T cells.12 This evidence concerns the gene CD8A and neoplasm.